Idex CorpIEX
Price$229.85Intrinsic value$196.2015% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $3.6B+9.7% YoYTTM through 30 Jun 2026
Net Income $519.5M+2.9% YoYTTM through 30 Jun 2026
Free Cash Flow $641.5MTTM through 30 Jun 2026

Margins

Current
Gross Margin44.9%
EBITDA Margin24.6%
Operating Margin19.4%
Net Margin14.5%

Returns

12.6%ROE
1.7%ROA
9.9%ROIC

Balance Sheet Health

Debt / Equity0.46x
Current Ratio3.39x
Net Debt$1.3B
Cash & Equivalents$621.3M

Quality Metrics

Altman Z-Score5.43
Piotroski F-Score8 / 9
FCF Margin17.9%
Rule of 4020.8
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $3.5B
Diluted EPS$6.95TTM
'19'20'21'22'23'24'25
FY2025: $6.41

Dividend

$2.17Per share, FY20260.96%Yield+0.5%5-yr growth

Capital Allocation

R&D Spend$70M
Capex Intensity2.1%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.